OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics Holdings Limited (NYSE: RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced ...

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first ...

Researchers from Hokkaido University and Toppan have developed a method to detect build-up of amyloid β in the brain, a characteristic of Alzheimer's disease, from biomarkers in blood samples.

SAN DIEGO--(BUSINESS WIRE)-- This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first ...

Syntec Optics Holdings, Inc. announced its collaboration on a new photonic biosensing technology that aims to revolutionize drug discovery and testing. By providing optical manufacturing support, ...

ROCHESTER, NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (OPTX), a leading provider of mission-critical products to advanced technology defense, biomedical, and ...

DexCom Inc. DXCM recently announced the launch of a proprietary Generative AI (GenAI) platform, making Dexcom the first Continuous Glucose Monitoring (CGM) manufacturer to integrate GenAI into glucose ...

Dexcom has launched a proprietary Generative AI platform. The company said that the new Dexcom GenAI platform will analyze individual health data patterns to reveal a direct association between ...

Biosensing has been valuable for detecting biomolecules, including novel coronavirus (SARS-CoV-2), but achieving both high sensitivity and rapidity has been challenging. Rapid and high-sensitivity ...

An unplugged electric instrument may function, but it sounds much better when it is connected to an amplifier. Similarly, toxins and other small molecules at low concentrations in the environment or ...